Gabriel Leung - Net Worth and Insider Trading

Gabriel Leung Net Worth

The estimated net worth of Gabriel Leung is at least $1 Million dollars as of 2024-03-29. Gabriel Leung is the Director of NovoCure Ltd and owns about 72,859 shares of NovoCure Ltd (NVCR) stock worth over $1 Million. Gabriel Leung is also the Director of Albany Molecular Research Inc and owns about 13,254 shares of Albany Molecular Research Inc (AMRI) stock worth over $288,142. Details can be seen in Gabriel Leung's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gabriel Leung has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).

Transaction Summary of Gabriel Leung

To

Gabriel Leung Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gabriel Leung owns 4 companies in total, including NovoCure Ltd () , Pernix Therapeutics Holdings Inc () , and Albany Molecular Research Inc () among others .

Click here to see the complete history of Gabriel Leung’s form 4 insider trades.

Insider Ownership Summary of Gabriel Leung

Ticker Comapny Transaction Date Type of Owner
NovoCure Ltd 2021-08-05 director
Pernix Therapeutics Holdings Inc 2018-05-22 director
Albany Molecular Research Inc 2015-03-02 director
Delcath Systems Inc 2011-03-30 director

Gabriel Leung Latest Holdings Summary

Gabriel Leung currently owns a total of 2 stocks. Among these stocks, Gabriel Leung owns 72,859 shares of NovoCure Ltd (NVCR) as of August 5, 2021, with a value of $1 Million and a weighting of 79.81%. Gabriel Leung also owns 13,254 shares of Albany Molecular Research Inc (AMRI) as of December 7, 2011, with a value of $288,142 and a weighting of 20.19%.

Latest Holdings of Gabriel Leung

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2021-08-05 72,859 15.63 1,138,786
AMRI Albany Molecular Research Inc 2011-12-07 13,254 21.74 288,142

Holding Weightings of Gabriel Leung


Gabriel Leung Form 4 Trading Tracker

According to the SEC Form 4 filings, Gabriel Leung has made a total of 23 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in NovoCure Ltd is the sale of 1,000 shares on August 5, 2021, which brought Gabriel Leung around $152,500.

According to the SEC Form 4 filings, Gabriel Leung has made a total of 0 transactions in Albany Molecular Research Inc (AMRI) over the past 5 years. The most-recent trade in Albany Molecular Research Inc is the acquisition of 8,000 shares on December 7, 2011, which cost Gabriel Leung around $19,200.

Insider Trading History of Gabriel Leung

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gabriel Leung Trading Performance

GuruFocus tracks the stock performance after each of Gabriel Leung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriel Leung is 15.25%. GuruFocus also compares Gabriel Leung's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriel Leung within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gabriel Leung's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gabriel Leung

Average Relative Return

119.86%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 22.03 15.25 5.51 119.86 111.33 90.2
Relative Return to S&P 500(%) 20.7 7.98 1.23 107.44 91.69 72.12

Gabriel Leung Ownership Network

Ownership Network List of Gabriel Leung

No Data

Ownership Network Relation of Gabriel Leung


Gabriel Leung Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Gabriel Leung is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .

NovoCure Ltd () Insider Trades Summary

Over the past 18 months, Gabriel Leung made no insider transaction in NovoCure Ltd (). Other recent insider transactions involving NovoCure Ltd () include a net sale of 75,808 shares made by Frank X Leonard , a net sale of 25,323 shares made by Pritesh Shah , and a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen .

In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd () in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 366,202 shares of NovoCure Ltd () were sold and 0 shares were bought by its insiders, resulting in a net sale of 366,202 shares.

NovoCure Ltd ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

Gabriel Leung Mailing Address

Above is the net worth, insider trading, and ownership report for Gabriel Leung. You might contact Gabriel Leung via mailing address: C/o Pernix Therapeutics Holdings, Inc., 10 North Park Place, Suite 201, Morristown Nj 07960.

Discussions on Gabriel Leung

No discussions yet.